GLP-1 mimetics as a potential therapy for nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GLP-1 mimetics as a potential therapy for nonalcoholic steatohepatitis

Published:2021-12-21 Issue: Volume: Page:
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Chen Yan,Xu Ying-na,Ye Chen-yu,Feng Wen-bo,Zhou Qing-tong,Yang De-hua,Wang Ming-wei

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-021-00836-9.pdf

Reference145 articles.

1. Stoffel M, Espinosa R, Le Beau MM, Bell GI. Human glucagon-like peptide-1 receptor gene. Diabetes. 1993;42:1215–8.

2. Merchenthaler I, Lane M, Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol. 1999;403:261–80.

3. Montrose-Rafizadeh C, Avdonin P, Garant MJ, Rodgers BD, Kole S, Yang H, et al. Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in Chinese hamster ovary cells. Endocrinology. 1999;140:1132–40.

4. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci USA. 1987;84:3434–8.

5. Lu M, Wheeler MB, Leng XH, Boyd AE 3rd. The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I (7-37). Endocrinology. 1993;132:94–100.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutraceutical and dietary measures with potential for preventing/controlling non-alcoholic fatty liver disease and its complications;Human Nutrition & Metabolism;2024-09

2. Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome;iScience;2024-02

3. Effects of GLP-1 and Other Gut Hormone Receptors on the Gastrointestinal Tract and Implications in Clinical Practice;American Journal of Gastroenterology;2023-10-19

4. Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase;Journal of Translational Medicine;2023-10-07

5. Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy;Pharmaceutics;2023-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3